65,437 trials
Type 2 Diabetes
Primary: Percentage of Patients Experiencing Adverse Events — 73.1 percentage of patients
Contact Lens Care
Primary: Mean Ex-Vivo Wetting Angle — 52.1; 59.6 Degrees
Knee Injuries
Primary: International Knee Documentation Committee (IKDC)Knee Form 2000 Score — 85.7; 87.2; 84.6 Score on a scale
Acute Myeloid Leukemia (AML) · Myelodysplastic Syndrome
Primary: Percentage of Participants With Objective Response (OR) — 0 Percentage of participants
Actinic Keratoses
Primary: Proportion of Patients With Complete Clearance of Actinic Keratoses (AK) Lesions — 42; 5 participants — p=0.001
Kidney Neoplasms
Primary: Percentage of Participants With Objective Response (OR) — 44.2 Percentage of participants
Rheumatoid Arthritis
Primary: Percentage of ACR20 (American College of Rheumatology 20% Improvement) Responders at Week 34 in Patients Randomized at Week 18 — 65.2; 67.1; 44.9 percentage of subjects
Angioplasty, Transluminal, Percutaneous Coronary · Coronary Arteriosclerosis · Peripheral Arteriosclerosis
Primary: Time to Hemostasis (TTH) — 4.68; 4.38; 20.05 Minutes — p=<0.0001
Obstructive Sleep Apnea · Respiratory Insufficiency
Primary: Usability Ratings of the Pixi Paediatric Mask Compared With the Child's Current Mask — 7.17; 5.83 units on a scale
Esophageal Cancer
Primary: The Number of Patients With Complete or Partial Response Rate of Single Agent ZD1839 in a Patient Population With Recurrent or Metastatic Cancer of the Esophagus or…
Actinic Keratosis
Primary: Complete Clearance of Actinic Keratoses (AK) Lesions — 67; 7 participants — p=<0.001
Lung Neoplasms · Carcinoma, Non-small Cell Lung
Primary: Percentage of Participants With Objective Response (OR) — 9.4 Percentage of participants
Pharmacokinetics
Primary: Area Under the Curve Over Dosing Interval at Steady State (AUC12,ss) Following IV Administration — 22.39 μg*h/mL
Healthy Volunteers
Primary: Area Under the Curve From Time Zero to Last Quantifiable Concentration (AUClast) — 79360.0; 77180.0; 20550.0; 18800.0 ng*hr/mL
Chronic Liver Disease
Primary: Number of Subjects With Likelihood of Cirrhosis Based on "Hepatic Impairment Score" (HIS) — 146 Participants — p=0.0924